Majid Kerolous, PharmD, MPH, is affiliated with AbbVie in North Chicago, Illinois. Kerolous has published on the use of cariprazine as an adjunctive treatment for major depressive disorder, focusing on patients with inadequate response to antidepressant therapy and the impact on anxiety symptoms. Contributions include randomized, placebo-controlled clinical trials analyzing cariprazine's efficacy in these clinical contexts. Frequent collaborators include Maurizio Fava, Chen Chen, and Gary S. Sachs.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
